Free Trial
NYSE:TMO

Thermo Fisher Scientific (TMO) Stock Price, News & Analysis

$536.02
-4.08 (-0.76%)
(As of 07/8/2024 ET)
Today's Range
$535.43
$542.96
50-Day Range
$533.93
$599.02
52-Week Range
$415.60
$603.82
Volume
1.14 million shs
Average Volume
1.66 million shs
Market Capitalization
$204.61 billion
P/E Ratio
34.38
Dividend Yield
0.29%
Price Target
$606.47

Thermo Fisher Scientific MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.72 Rating Score
Upside/​Downside
13.1% Upside
$606.47 Price Target
Short Interest
Healthy
0.84% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.44
Upright™ Environmental Score
News Sentiment
0.82mentions of Thermo Fisher Scientific in the last 14 days
Based on 14 Articles This Week
Insider Trading
Selling Shares
$12.53 M Sold Last Quarter
Proj. Earnings Growth
10.81%
From $21.65 to $23.99 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.90 out of 5 stars

Medical Sector

19th out of 876 stocks

Measuring & Controlling Devices, Not Elsewhere Classified Industry

1st out of 9 stocks

TMO stock logo

About Thermo Fisher Scientific Stock (NYSE:TMO)

Thermo Fisher Scientific Inc. is a prominent American supplier of scientific instrumentation, reagents, consumables, and software services. The company was formed in 2006 through the merger of Thermo Electron and Fisher Scientific, established players in the scientific and laboratory equipment industry. Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific operates in the life sciences, healthcare, and analytical technologies sectors.

The company's history dates back to 1956 when Thermo Electron was co-founded by George N. Hatsopoulos and Peter M Nomikos, focusing on analytical and laboratory products. Fisher Scientific, founded in 1902 by Chester G. Fisher, supplied laboratory equipment, chemicals, and services. The merger in 2006 created Thermo Fisher Scientific, combining their expertise and product portfolios to provide comprehensive solutions to scientific and healthcare communities.

Thermo Fisher Scientific's mission is to enable customers to make the world healthier, cleaner, and safer through its innovative products and services. They strive to advance research, enhance healthcare and support analytical applications globally. The company offers a wide range of products and services under the brand names of Thermo Scientific, Fisher Scientific, and others. Their offerings include advanced instruments, consumables, reagents, software, and services tailored for research, diagnostics, and industrial applications. Thermo Fisher Scientific's products are utilized by academic institutions, pharmaceutical companies, biotech firms, healthcare providers, and research organizations worldwide.

Thermo Fisher Scientific's management team is led by Mr. Marc N. Casper, who serves as Chairman, President, and Chief Executive Officer. Under his leadership, the company has grown remarkably and expanded its global footprint. 

Thermo Fisher Scientific has exhibited strong financial performance in recent years. The company's annual revenue and net income have been increasing yearly. The net profit margin stands at over 10%, demonstrating the company's ability to convert revenue into profit efficiently. The company maintains a healthy financial position with a debt-to-equity ratio indicating that it relies less on debt financing and holds a strong balance sheet confirming its financial stability and ability to meet short-term obligations.

Thermo Fisher Scientific's valuation metrics show positive signs. The market has expressed confidence in the company's future earnings potential, and that confidence is reflected in its valuation metrics. This indicates that investors are optimistic about the company's future growth prospects. Thermo Fisher Scientific's stock has demonstrated solid performance, which suggests investors' positive sentiment toward the company. However, various factors, including macroeconomic conditions, industry trends, and company-specific developments, can influence market performance.

Thermo Fisher Scientific operates in the measuring and controlling devices industry, specifically life sciences tools and services. The company is a dominant player in this industry, benefiting from its vast product portfolio and global reach. Its comprehensive offerings and strong customer relationships provide a competitive advantage over peers. With a diverse customer base and innovative solutions, the company is well-positioned to capitalize on the growing demand for advanced scientific and healthcare products. Thermo Fisher Scientific enjoys a competitive edge in the industry due to its extensive product range, technical expertise, and established market presence. The company's continuous investments in research and development enable it to introduce cutting-edge products that cater to evolving customer needs. Additionally, strategic acquisitions have expanded its capabilities, strengthening its competitive positioning.

The company has numerous growth opportunities in the life sciences, healthcare, and industrial sectors. The rising demand for innovative research tools, diagnostic solutions, and analytical instruments presents attractive prospects for Thermo Fisher Scientific. The company's strong global presence allows it to tap into emerging markets and cater to a diverse customer base. Thermo Fisher Scientific possesses several competitive advantages, including its vast product portfolio, research capabilities, and established reputation in the industry. Its ability to provide end-to-end solutions across multiple sectors sets it apart from competitors. Moreover, strategic partnerships and acquisitions have facilitated access to new technologies and expanded its customer base, bolstering its competitive position.

Despite its strengths, Thermo Fisher Scientific faces certain risks and challenges. Market competition from established players and emerging companies could impact market share and pricing power. Global economic conditions and regulatory changes may influence the company's operations and profitability. Moreover, unexpected events like supply chain disruptions or technology shifts could pose challenges. Thermo Fisher Scientific employs robust risk management strategies to mitigate potential risks. These include diversifying its product portfolio, investing in research and development, and maintaining financial stability. The company continuously monitors market dynamics to adapt to changing trends and demands. Additionally, strong governance and compliance practices ensure adherence to regulatory requirements.

TMO Stock Price History

TMO Stock News Headlines

Morgan Stanley exterior sign and trademark logo.
Top 4 Fastest Growing S&P 500 Dividends: Buy, Sell, or Hold?
Dividends are a leading reason to buy a stock because the stock pays you to own it. Growing dividend distributions are more valuable than those that aren't; by extension, distributions growing faster than average are even more valuable.
Morgan Stanley exterior sign and trademark logo.
Top 4 Fastest Growing S&P 500 Dividends: Buy, Sell, or Hold? (TMO)
The fastest-growing dividends in the S&P 500 are good buys, but that doesn't mean it's time to buy them now; only one is accelerating distribution growth.
50-year Wall Street Legend: “Prepare for a cash avalanche”
The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the start of the year.
3 Biotech Stocks Turning DNA Dreams Into Dollars
50-year Wall Street Legend: “Prepare for a cash avalanche”
The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the start of the year.
See More Headlines
Receive TMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thermo Fisher Scientific and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/15 Dividend
3/14/2024
Dividend Payable
4/15/2024
Last Earnings
4/24/2024
Ex-Dividend for 7/15 Dividend
6/14/2024
Today
7/09/2024
Dividend Payable
7/15/2024
Next Earnings (Confirmed)
7/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Measuring & controlling devices, not elsewhere classified
Sub-Industry
Life Sciences Tools & Services
CUSIP
88355610
Employees
122,000
Year Founded
1956

Price Target and Rating

Average Stock Price Target
$606.47
High Stock Price Target
$670.00
Low Stock Price Target
$475.00
Potential Upside/Downside
+13.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.72
Research Coverage
18 Analysts

Profitability

Net Income
$6.00 billion
Pretax Margin
15.35%

Debt

Sales & Book Value

Annual Sales
$42.49 billion
Cash Flow
$30.23 per share
Book Value
$120.93 per share

Miscellaneous

Free Float
380,418,000
Market Cap
$204.61 billion
Optionable
Optionable
Beta
0.77

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Should I Buy Thermo Fisher Scientific Stock? TMO Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Thermo Fisher Scientific Inc.:

  • Thermo Fisher Scientific Inc. has a strong financial performance with a market cap of $206.17 billion, indicating stability and potential for growth.
  • The company consistently beats earnings estimates, as seen in the latest quarterly report where they surpassed the consensus EPS by $0.41, showcasing strong operational efficiency.
  • Analysts have a positive outlook on the stock, with a consensus price target of $607.94, indicating potential for price appreciation.
  • Thermo Fisher Scientific Inc. provides a diverse range of life sciences solutions, analytical instruments, and biopharma services, diversifying its revenue streams and reducing risk.
  • The company has a low dividend payout ratio of 10.01%, leaving room for potential dividend increases or reinvestment in growth opportunities.

Cons

Investors should be bearish about investing in Thermo Fisher Scientific Inc. for these reasons:

  • The stock price has experienced fluctuations, with a 50-day moving average price of $572.32 and a 200-day moving average price of $563.22, indicating potential volatility.
  • Insiders have been selling company stock, with recent transactions totaling 22,000 shares worth $12,532,780, which may raise concerns about insider sentiment.
  • While the company has a strong financial position, the current P/E ratio of 34.36 may be considered high by some investors, potentially impacting valuation.
  • Thermo Fisher Scientific Inc. operates in a competitive industry, facing challenges from other major players in the life sciences and biopharma sectors.
  • The company's debt-to-equity ratio of 0.68 may indicate a moderate level of leverage, which could pose risks in times of economic uncertainty.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, July 7, 2024. Please send any questions or comments about these Thermo Fisher Scientific pros and cons to contact@marketbeat.com.

TMO Stock Analysis - Frequently Asked Questions

How have TMO shares performed this year?

Thermo Fisher Scientific's stock was trading at $530.79 at the beginning of 2024. Since then, TMO shares have increased by 1.0% and is now trading at $536.02.
View the best growth stocks for 2024 here
.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc. (NYSE:TMO) announced its earnings results on Wednesday, April, 24th. The medical research company reported $5.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.70 by $0.41. The medical research company had revenue of $10.35 billion for the quarter, compared to analyst estimates of $10.14 billion. Thermo Fisher Scientific had a net margin of 14.20% and a trailing twelve-month return on equity of 18.45%.
Read the conference call transcript
.

Is Thermo Fisher Scientific doing a stock buyback?

Thermo Fisher Scientific's Board of Directors approved a share repurchase program on Tuesday, November 14th 2023, which allows the company to buy back $4,000,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 2.2% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's management believes its stock is undervalued.

What is Marc N. Casper's approval rating as Thermo Fisher Scientific's CEO?

1,642 employees have rated Thermo Fisher Scientific Chief Executive Officer Marc N. Casper on Glassdoor.com. Marc N. Casper has an approval rating of 87% among the company's employees.

Does Thermo Fisher Scientific have any subsidiaries?

The following companies are subsidiaries of Thermo Fisher Scientific: Henogen, Phinotex, Qiagen, Brammer Bio, HighChem, Gatan Inc, IntegenX, and others.

Who are Thermo Fisher Scientific's major shareholders?

Top institutional investors of Thermo Fisher Scientific include DNB Asset Management AS (0.05%), Douglas Lane & Associates LLC (0.05%), Confluence Investment Management LLC (0.02%) and Neville Rodie & Shaw Inc. (0.02%). Insiders that own company stock include Marc N Casper, Stephen Williamson, Gianluca Pettiti, Michel Lagarde, Jim P Manzi, Michael A Boxer, Debora L Spar and Mark Stevenson.
View institutional ownership trends
.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Thermo Fisher Scientific own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Thermo Fisher Scientific investors own include Johnson & Johnson (JNJ), Home Depot (HD), NVIDIA (NVDA), Cisco Systems (CSCO), Alibaba Group (BABA), Walt Disney (DIS).

This page (NYSE:TMO) was last updated on 7/9/2024 by MarketBeat.com Staff

From Our Partners